Diabetes and Hypertension: Preventing a Toxic Combination - References

References:

1. The current state of diabetes mellitus in India - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920109/)
2. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet, 2011, 378(9785):31–40.
3. R Gupta, Trends in hypertension epidemiology in India, Journal of Human Hypertension (2004) 18, 73–78. - doi:10.1038/sj.jhh.1001633
4. Carmassi F, Morale M, Puccetti R, DeNegri F, Monzani F, Navalesi R, Mariani G. Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus. Thromb Res. 1992;67:643-654.
5. Landin K, Tengborn L, Smith U. Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease. J Intern Med. 1990;227:273-278.
6. Ford I, Singh TP, Kitchen S, Makris M, Ward JD, Preston FE. Activation of coagulation in diabetes mellitus in relation to the presence of vascular complications. Diabet Med. 1991;8:322-329

Author: Dr. Christopher Barry

Editor: Dr. Simi Paknikar

Technically Checked by: Lingaraj